Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 8
Submit an article Journal homepage
200
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Unusual Presentation of Acute Hydroxychloroquine Retinopathy

You-Yang Liana Department of Ophthalmology, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei City, Taiwan (R.O.C.)View further author information
, MD,
Yi-Cih Maa Department of Ophthalmology, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei City, Taiwan (R.O.C.)View further author information
, MD &
Cheng-Kuo Chenga Department of Ophthalmology, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei City, Taiwan (R.O.C.);b School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan (R.O.C.);c School of Medicine, National Taiwan University, Taipei, TaiwanCorrespondence[email protected]
View further author information
, MD
Pages 1720-1723 | Received 16 Feb 2022, Accepted 06 Jun 2022, Published online: 08 Jul 2022

References

  • Chen E, Brown DM, Benz MS, et al. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the “flying saucer” sign). Clin Ophthalmol. 2010;4:1151. doi:10.2147/OPTH.S14257.
  • Lian F, Zhou J, Wang Y, Xu H, Yang X. FRI0338 hydroxychloroquine may help to improve the in vitro fertilization-embryo transfer outcomes in ana and ds-dna positive patients. Ann Rheum Dis. 2018;77: 705-705.
  • Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014 Dec;132(12):1453–1460. doi:10.1001/jamaophthalmol.2014.3459.
  • Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology. 2002;109:1377–1382. doi:10.1016/S0161-6420(02)01168-5.
  • Marks J. Chloroquine retinopathy: is there a safe daily dose? Ann Rheum Dis. 1982;41:52–58. doi:10.1136/ard.41.1.52.
  • Kellner S, Weinitz S, Farmand G, Kellner U. Cystoid macular oedema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation. Br J Ophthalmol. 2014;98:200–206. doi:10.1136/bjophthalmol-2013-303897.
  • Parikh VS, Modi YS, Au A, et al. Nonleaking cystoid macular edema as a presentation of hydroxychloroquine retinal toxicity. Ophthalmology. 2016;123:664–666. doi:10.1016/j.ophtha.2015.09.011.
  • PLAQUENIL®(hydroxychloroquine sulfate) U.S. Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009768s037s045s047lbl.pdf Revised January, 2017. Reference ID: 4047416
  • Chang CY, Sheu SJ. Macular edema might be a rare presentation of hydroxychloroquine-induced retinal toxicity. Taiwan J Ophthalmol. 2017;7:56. doi:10.4103/tjo.tjo_26_17.
  • Pasaoglu I, Onmez FE. Macular toxicity after short-term hydroxychloroquine therapy. Indian J Ophthalmol. 2019;67:289. doi:10.4103/ijo.IJO_732_18.
  • Hernández LB, Monferrer CA, Hernández MG, Cervera ET. Early macular toxicity following 2 months of hydroxychloroquine therapy. Arch Soc Esp Oftalmol. 2018;93:e20–e21. doi:10.1016/j.oftal.2017.12.004.
  • Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16:155–166. doi:10.1038/s41584-020-0372-x.
  • Wu JJ, Ai CZ, Liu Y, et al. Interactions between phytochemicals from traditional Chinese medicines and human cytochrome P450 enzymes. Curr Drug Metab. 2012;13:599–614. doi:10.2174/1389200211209050599.
  • Kimura Y, Ito H, Ohnishi R, Hatano T. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem Toxicol. 2010 Jan;48(1):429–435. doi:10.1016/j.fct.2009.10.041.
  • Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123:1386–1394. doi:10.1016/j.ophtha.2016.01.058.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.